SPONSORED

RNMBY Riches: Susie Lee’s Defense Deal or Shady Steal?

Unpacking the Hype Around a Congresswoman’s Defense Stock Triumph

•• 1 Min
RNMBY Riches: Susie Lee’s Defense Deal or Shady Steal?

Buckle up, stock market sleuths! A viral X post from @PelosiTracker_ has set tongues wagging, claiming that following Rep. Susie Lee’s 2024 purchase of Rheinmetall AG ($RNMBY) could’ve netted you a jaw-dropping 330% return by now. But is this German defense stock really a golden ticket, or are we chasing a congressional mirage? Let’s dive into the numbers, the controversy, and why this story has investors and ethicists buzzing.

The Viral Claim That Caught Fire

In May 2024, @PelosiTracker_, the self-appointed watchdog of congressional stock trades, flagged a curious move by Nevada’s Rep. Susie Lee. The Democratic congresswoman snapped up shares of Rheinmetall AG ($RNMBY), a German powerhouse in weapons manufacturing, in a trade valued between $1,001 and $15,000. Why the raised eyebrows? Two reasons:

  1. No Politician Had Touched RNMBY Before – Lee was the first to dip her toes into this stock, per congressional records.
  2. Her Committee Seat Screams Conflict – As a member of the House Subcommittee on Military Construction, Veterans Affairs, and Related Agencies, Lee’s role intersects with defense spending, making her stock pick a lightning rod for scrutiny.

Fast-forward to May 2025, and @PelosiTracker_ crowed that anyone who followed Lee’s trade would be up 330%. Cue the champagne—or maybe not. Let’s crunch the numbers to see if this claim holds water.

The Real Numbers: 247% Gain, Not 330%

According to congressional trade reports from Capitol Trades and Quiver Quantitative, Lee bought RNMBY on May 10, 2024, at $115.347 per share. As of 9:05 AM PDT on May 20, 2025, Yahoo Finance pegs RNMBY at $400.50. Let’s do the math:

  • Purchase Price: $115.347
  • Current Price: $400.50
  • Gain: ($400.50 - $115.347) / $115.347 × 100 = 247.2%

That’s a stellar return—enough to make any investor’s heart skip a beat—but it’s a far cry from the 330% hyped in the X post. To hit 330%, the purchase price would’ve needed to be around $93.14, but no data supports this. The discrepancy? Likely a mix of exaggeration and sloppy math, a classic social media cocktail designed to grab eyeballs.

Why Rheinmetall? The Defense Stock Surge

Rheinmetall AG, a titan in defense manufacturing, has been riding high. With global tensions fueling demand for military hardware, RNMBY’s stock has soared from a 52-week low of $101.13 to a high of $401.00, per Yahoo Finance. Lee’s purchase timing was impeccable, but was it luck, skill, or something murkier? Her subcommittee role raises questions, as it oversees military construction budgets that could indirectly benefit defense contractors like Rheinmetall.

The controversy isn’t new. Congressional stock trading has long been a hot potato, with critics arguing that lawmakers’ access to privileged information gives them an unfair edge. The STOCK Act of 2012 mandates timely trade disclosures, but enforcement has been spotty, and Lee’s RNMBY buy has reignited the debate. As Nevada News and Views noted, her trades have drawn attention from figures like Dave Portnoy, who called her stock-picking prowess “too good to ignore.”

Should You Follow Politicians’ Trades?

The allure of mimicking congressional portfolios is undeniable—247% returns don’t grow on trees. Platforms like Quiver Quantitative and Capitol Trades make it easy to track these moves, and @PelosiTracker_ has built a cult following by spotlighting them. But before you YOLO your savings into RNMBY, consider the risks:

  • Past Performance Isn’t a Crystal Ball: A hot stock today could tank tomorrow.
  • Ethical Quagmires: Following trades tied to potential conflicts of interest might not sit well with your conscience.
  • Delayed Reporting: Congressional disclosures often lag, meaning you’re buying at a different price than the politician.

The Bigger Picture: Ethics vs. Profits

Susie Lee’s RNMBY trade, while profitable, underscores a broader issue: should lawmakers be allowed to trade stocks at all? Critics argue for bans, citing the appearance of insider trading, while defenders claim it’s their right as private citizens. With no concrete evidence of wrongdoing in Lee’s case, the debate rages on, fueled by posts like @PelosiTracker_’s that blend fact with flair.

Final Verdict: A Win, But Not That Big

Rep. Susie Lee’s Rheinmetall bet was a home run, delivering a 247% gain in just over a year—an enviable return for any investor. But the 330% claim? That’s a stretch, and @PelosiTracker_ owes us a fact-check. Whether you see Lee as a stock-picking savant or a symbol of congressional privilege, one thing’s clear: her trade has sparked a conversation that’s not going away.

So, will you chase the next congressional stock tip, or steer clear of the ethical gray zone?

Sources: Yahoo Finance, Capitol Trades, Quiver Quantitative, Nevada News and Views, The Nevada Globe

Most Popular News

  1. SpaceX’s $8B Spectrum Deal Sends AT&T, Verizon, and T-Mobile Plummeting
  2. Is Project Vault Securing America’s Supply Chain or Squeezing It to the Breaking Point?
  3. Why Gautam Lohia Shifted from Global Consulting to Reboot a $20M Tech Micro-Cap
  4. Everyday Luxury, Unstoppable Scale: Aritzia Delivers 44% Net Revenue Growth
  5. Can Navy SEAL Leadership and Big Tech Scale Revolutionize Airborne Threat Detection?

Disclaimer


This report should not be viewed as investment advice or as an offer to buy or sell any securities or as an invitation or solicitation of an offer to buy or sell any securities. Neither the author of this report, its publisher, nor any other person associated with the publication of this report, are registered brokers, investment dealers, investment advisers, or financial advisers. The information in this report has not been tailored to the particular needs or circumstances of readers and should not be relied upon as investment advice or recommendations to purchase or sell any of the securities presented in this report. Readers seeking investment advice should contact qualified and registered brokers, investment dealers, investment advisers, or financial advisers prior to making any decision to buy or sell any of the securities referred to in this report. The information in this report should not be construed as investment, legal, or tax advice. No recommendation is made as to whether an investment in the presented securities is suitable for any reader in light of the reader’s particular circumstances.

Readers are cautioned that the publisher of this report covers exclusively securities that carry a high degree of volatility. Investing in such securities is highly speculative and carries a high degree of risk. Investors in such securities could lose all or a substantial portion of their investment. Only those investors who can afford to lose all or a substantial portion of their investment should consider investing in the securities referred to in this report.

This report may include information obtained from publicly available sources, including third-party reports or analysis. Neither the author nor publisher of this report, nor www.juniorstocks.com or its owners, have undertaken any independent investigation into the factual information used in this report, and the information in this report is provided without any warranty of any kind. No representations or warranties are provided regarding the accuracy or completeness of the information provided in this report. Statements of opinion or belief are those of the authors and/or publisher of this report. These statements of opinion or belief are expressions of the author’s and/or publisher’s judgment, and there is no guarantee that those judgments will turn out to be correct. No inference should be drawn that the author and/or publisher have any special or greater knowledge about the presented companies or their securities, or any particular expertise in the industries or markets in which the company operates. Readers should conduct their own due diligence and seek professional advice prior to investing in any securities presented on Juniorstocks.com.

Certain statements in this report constitute “forward-looking” statements. Forward-looking statements often, but not always, are identified by the use of words such as “seek,” “anticipate,” “believe,” “plan,” “estimate,” “expect,” “targeting,” and “intend” and statements that an event or result “may,” “will,” “should,” “could,” or “might” occur or be achieved and other similar expressions. Forward-looking statements express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance; they are not statements of historical facts and should not be viewed as any guarantee of any future result. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. The author and/or publisher of this report disclaims any obligation to update the forward-looking statements in this report, whether as a result of new information, future events, or results or otherwise. There is no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

The information provided in this report is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to applicable law or regulation, or would subject the author or publisher of this report to any registration requirement in such jurisdiction or country.

Information about the editor of this publication:
Juniorstocks.com is a service provided by Piccadilly Capital Group, Office 66, 101 Clapham High Street, London, SW4 7TB, UK. Piccadilly Capital Group is not the publisher of this report and was not paid for the publication of this report. Piccadilly Capital Group seeks to generate web traffic and a growing number of followers through the publication of articles or reports. Directors, officers, and other insiders of the publisher own an interest in Piccadilly Capital Group. Piccadilly Capital Group does not endorse or recommend the business, products, services, or securities of any company mentioned on www.juniorstocks.com. Piccadilly Capital Group will not share your information with any outside third parties. Due to the new data protection basic regulation, we ask you to read our data protection declaration carefully.

Note on copyright:
The contents published on this website and on connected media (e.g., e-mail, X, Facebook) are subject to applicable copyright and ancillary copyright laws. Any use not permitted by applicable copyright and ancillary copyright laws requires the prior written consent of the provider or the respective rights holder. In particular, this applies to the duplication, editing, translation, storage, processing, or reproduction of content in databases or other electronic media and systems. Contents and rights of third parties are marked as such. Unauthorized reproduction or transmission of individual contents or complete pages is not permitted and is punishable by law. Only the production of copies and downloads for personal, private, and non-commercial use is permitted. Links to the provider's website are always welcome and do not require the consent of the provider of the website. Photos and images on the website may not be shared unless the publisher itself has acquired the initial rights from authorized sources. The presentation of this website in external frames is only allowed with written permission. If you notice any violations, please inform us. Please note: The content of our articles, emails, or other publications or social networks such as X, LinkedIn or Facebook is exclusively intended for the designated addressee(s). If you are not the addressee of these articles, emails, or other publications in the market letter or social networks such as Twitter or Facebook or his or her legal representative, please note that any form of publication, reproduction, or distribution of the content of these articles, emails, or other publications in the market letter or social networks such as X, LinkedIn or Facebook is prohibited. Falsifications of the original content of this message during data transmission cannot be excluded in principle.